Update April 21, 2015- By Steven E. Greer, MD
As a direct result of our posting of the letter, below, the New York Times then national TV news have picked up this story. The bad press forced Dr. Oz to make a statement on his TV show that he “Will not be Read more »
Cardiac surgery, Columbia University, Op-Ed, Policy | apples49 | 
July 9, 2015 6:00 am | 
Comments (0)
Interviewed by Steven E. Greer, MD
In Part 1 of our interview with Robert Klitzman, MD, ethics professor at Columbia University, we discuss the 23andMe genetic test kit company and why the FDA made them stop marketing the tests.
Columbia University, FDA, Policy | apples49 | May 30, 2015 6:37 pm | Comments (0)
January 18, 2015- By Steven E. Greer, MD
On July 20th, 2011, the FDA convened an advisory committee to help it determine whether to approve the first ever TAVR device called the Sapien, made by Edwards Lifesciences. I was a public speaker raising the Read more »
Cardiac surgery, Cardiology/interventional, CMS Medicare Medicaid, Columbia University, FDA, JAMA, Medical Devices, Neurology, Op-Ed, Policy, Univ Pennsylvania | apples49 | January 25, 2015 6:58 pm | Comments (0)
Interviewed by Steven E. Greer, MD
In Part 3 of our interview with Robert Klitzman, MD, ethics professor at Columbia University, we discuss how Google and other companies want to get into the business of managing sensitive data found in electronic medical records. Google Health failed in 2001, but they have other companies in the works. How might the data be abused and resold?
Columbia University, Policy | apples49 | March 20, 2014 8:16 am | Comments (0)
Interviewed by Steven E. Greer, MD
In Part 2 of our interview with Robert Klitzman, MD, from Columbia University, he discusses the laws protecting the data gathered during genetic tests, whether insurance companies can use the data to deny coverage, and the how for-profit companies can sell those data for product marketing.
Columbia University, FDA, Policy | apples49 | February 22, 2014 6:41 pm | Comments (0)
